H. Wirtz (Leipzig, Germany), A. Ishizaka (Tokyo, Japan)
Mitochondrion-derived reactive oxygen species mediate mechanotransduction in A549 cells L. Pinhu, M. J. Griffiths (London, United Kingdom)
| |
Autonomic dysfunction in moderate acute lung injury induced by paraquat M. D. G. Rodrigues-Machado, W. A. Zin, C. H. Xavier, M. V. Caliari, M. J. Campagnole-Santos, R. A. S. Santos (Belo Horizonte, Rio de Janeiro, Brazil)
| |
Change of mRNA transcription in rat lung pericytes after treatment of LPS or TNF-α J. W. Shin, S. Y. Lim, J. Y. Kim, I. W. Park, B. W. Choi (Seoul, Republic Of Korea)
| |
Comparison of mini-BAL and edema fluid in acute lung injury using proteomic analysis D. W. Chang, G. Colucci, S. Hayashi, T. King, R. Bumgarner, T. R. Martin, G. M. Domenighetti (Seattle, United States Of America; Locarno, Switzerland)
| |
sGC activator BAY 412272 attenuates ischemia/reperfusion injury of the lung B. Egemnazarov, A. Sydykov, R. T. Schermuly, N. Weissmann, W. Seeger, F. Grimminger, H. A. Ghofrani (Giessen, Germany)
| |
Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung J. Varet, D. Bates, S. J. Harper, A. B. Millar (Bristol, United Kingdom)
| |
Endothelial- but not leukocytic-NOX2 mediates vascular injury in ischemia/reperfusion syndrome of the lung A. Sydykov, B. Egemnazarov, R. T. Schermuly, N. Weissmann, W. Seeger, F. Grimminger, H. A. Ghofrani (Giessen, Germany)
| |
Small interfering RNAs targeting β-catenin attenuate epithelial-mesenchymal transition in vitro J. Fukumoto, M. Yamada, N. Hamada, T. Maeyama, M. Yoshimi, K. Kuwano, Y. Nakanishi (Fukuoka, Japan)
| |
Increased alveolar epithelial expression of dimethylarginine dimethylaminohydrolase 2 in idiopathic pulmonary fibrosis S. S. Pullamsetti, R. Dumistrasu, R. Savai, B. K. Dahal, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, A. Guenther, R. T. Schermuly (Giessen, Germany)
| |
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) M. Wygrecka, P. Markart, A. Guenther, K. T. Preissner (Giessen, Germany)
| |
The mechanism of epithelial-mesenchymal transition (EMT) in pulmonary fibrosis M. Yamada, M. Yoshimi, N. Hamada, T. Maeyama, J. Fukumoto, K. Kuwano, Y. Nakanishi (Fukuoka, Japan)
| |
Advanced glycation endproducts (AGE) contribute to the expression of pro-fibrotic cytokines and collagen production in a cell type dependent manner M. A. Queisser, M. Wygrecka, F. M. Kouri, K. T. Preissner (Giessen, Germany)
| |
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression Y. Nishii, E. C. Gabazza, T. Takagi, T. Maruyama, H. Nakahara, H. Fujimoto, J. Maruyama, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Japan)
| |
Characterisation of the dose response of a human airway epithelium model to tobacco smoke components D. Balharry, K. Sexton, K. Bérubé (Cardiff, United Kingdom)
| |
TRAIL and Bax-mediated apoptosis, pathways by which apoptosis may be induced in emphysema M. C. Morissette, J. Parent, J. Milot (Québec, Canada)
| |
A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples B. Casado, L. K. Pannell, M. Luisetti, I. Cerveri, E. Ansaldo, E. Pozzi, P. Boschetto, I. Ferrarotti, C. E. Mapp, L. M. Fabbri, P. Iadarola, J. N. Baraniuk (Pavia, Ferrara, Modena, Italy; Mobile, Washington, United States Of America)
| |
Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD A. Iglesias, X. Busquets, J. Vidal, J. Garcia, J. Pons, D. Blanquer, E. Sala, A. G. N. Agusti, B. G. Cosio (Palma de Mallorca, Spain)
| |
A functional sequence variant of CCL5 is associated with non-emphysematous phenotype of COPD N. Hizawa, H. Makita, Y. Nasuhara, T. Betsuyaku, S. Konno, M. Nishimura, Hokkaido COPD Cohort Study Group (Sapporo, Japan)
| |
The use of toxicogenomics to identify biomarkers of exposure in an airway epithelium model exposed to tobacco smoke components K. Sexton, D. Balharry, T. Jones, K. Berube (Cardiff, United Kingdom)
| |
The promoter polymorphism -1562C/T in matrix metalloproteinase-9 and COPD severity D. G. Yanbaeva, G. F. Korytina, L. Z. Akhmadishina, S. Z. Zagidullin, T. V. Victorova (Ufa, Russian Federation)
| |